Virax Biolabs Group Limited
VRAX · NASDAQ
9/30/2025 | 3/31/2025 | 9/30/2024 | 3/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $3,345 | $4,229 | $7,286 | $3,589 |
| Short-Term Investments | $0 | $0 | $96 | $0 |
| Receivables | $176 | $31 | $26 | $218 |
| Inventory | $54 | $95 | $261 | $60 |
| Other Curr. Assets | $0 | $0 | $24 | $0 |
| Total Curr. Assets | $4,149 | $4,894 | $8,033 | $4,380 |
| Property Plant & Equip (Net) | $1,566 | $1,533 | $1,363 | $1,104 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $40 | $46 | $50 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | -$40 | $0 | -$50 |
| Total NC Assets | $1,566 | $1,533 | $1,410 | $1,104 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $5,715 | $6,427 | $9,443 | $5,484 |
| Liabilities | – | – | – | – |
| Payables | $42 | $56 | $119 | $46 |
| Short-Term Debt | $196 | $32 | $223 | $0 |
| Tax Payable | $11 | $7 | $0 | $12 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $0 | $60 | $115 | $0 |
| Total Curr. Liab. | $365 | $673 | $694 | $169 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $276 | $292 | $332 | $176 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $342 | $345 | $380 | $224 |
| Total Liabilities | $642 | $965 | $1,026 | $345 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $7 | $4 | $4 | $3 |
| Retained Earnings | -$26,928 | -$24,589 | -$21,284 | -$18,528 |
| AOCI | $32,233 | $30,281 | $29,925 | $23,892 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | $5,312 | $5,696 | $8,645 | $5,367 |
| Supplemental Information | – | – | – | – |
| Minority Interest | -$238 | -$234 | -$228 | -$228 |
| Total Liab. & Tot. Equity | $5,715 | $6,427 | $9,443 | $5,484 |
| Net Debt | -$3,150 | -$4,196 | -$7,063 | -$3,589 |